Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
03/2007
03/14/2007CN1927843A Compound of 2-substituted alkylacrylate and application thereof
03/14/2007CN1304380C Benzo[alpha]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II
03/14/2007CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals
03/13/2007US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
03/13/2007US7189755 Pyrrolidine melanocortin-specific compounds
03/13/2007US7189728 Inhibitors of dipeptidyl peptidase IV
03/13/2007US7189724 For therapy of viral diseases
03/13/2007US7189722 Aryl spirohydantoin CGRP receptor antagonists
03/13/2007US7189719 Sodium channel blockers
03/13/2007US7189483 Phenothiazine, phenoxazine, or phenazine derivatives; organophotoreceptor comprising electricoconductive substrate and photoconductive element; mechanical, electrostatic, and solubility properties; used with toners for quality images
03/08/2007WO2007005774A9 Novel derivatives of amino acids for treatment of obesity and related disorders
03/08/2007US20070055065 3-amidinophenylalanine derivatives such as N-(2-aminoethyl)-1-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperidine-4-carboxamide, used as inhibitors of matriptase, for the prophylaxis of tumors
03/08/2007US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
03/08/2007CA2618970A1 Lisofylline analogs and methods for use
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758865A1 Pyridine analogs as c5a antagonists
03/07/2007EP1758861A1 Dpp-iv inhibitors
03/07/2007CN1926094A Amide derivatives, process for production of the same, and method for application thereof as insecticide
03/07/2007CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
03/06/2007US7186834 Substituted iminoazines
03/06/2007US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
03/06/2007US7186735 Vasodilation; cardiovascular disorders; anticoagulants
03/06/2007US7186725 Anti-inflammatory compositions and methods
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186723 Tyrosine kinase inhibitors
03/06/2007US7186721 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
03/06/2007US7186719 Antibacterial agents
03/06/2007CA2200898C Process for the preparation of arylamides of heteroaromatic carboxylic acids
03/01/2007WO2007024922A1 Immunosuppressant compounds and compositions
03/01/2007WO2007024833A1 Anthranilamides for controlling invertebrate pests
03/01/2007WO2007023882A1 Derivative having ppar agonistic activity
03/01/2007WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors
03/01/2007WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
03/01/2007US20070049602 Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3
03/01/2007CA2621164A1 Derivative having ppar agonistic activity
03/01/2007CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
03/01/2007CA2619101A1 Immunosuppressant compounds and compositions
03/01/2007CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors
02/2007
02/28/2007EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
02/28/2007EP1757595A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
02/28/2007EP1756119A1 Collection of traceable compounds and uses thereof
02/28/2007EP1756060A1 Therapeutic compounds: pyridine as scaffold
02/28/2007EP1755605A2 Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease
02/28/2007EP1687856B1 Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives
02/28/2007CN1922160A Compounds
02/28/2007CN1921893A Catalytic radiofluorination
02/28/2007CN1302002C Hydroxylamine esters as polymerization initiators
02/28/2007CN1301973C Heterocyclic derivatives and medicines
02/28/2007CN1301964C Inhibitors of alpha 4 mediated cell adhesion
02/27/2007US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
02/22/2007WO2006105051A3 Synthesis of diketopiperazines
02/22/2007US20070043217 Method for the distillative separation of mixtures containing ethyleneamines
02/22/2007US20070043056 5-Substituted-2-arylpyrazines
02/22/2007DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses
02/21/2007EP1754703A2 N-Heterocyclic derivatives as nos inhibitors
02/21/2007EP1753713A2 Synthesis of tetracyclines and analogues thereof
02/21/2007EP1753429A1 Modulators of muscarinic receptors
02/21/2007EP1501508B1 Inhibitors of histone deacetylase
02/21/2007EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
02/21/2007CN1918135A Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof
02/21/2007CN1918133A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1916009A Process for preparing amine platinum complexes
02/21/2007CN1301254C Preparation of catifloxacin and purifying method
02/21/2007CN1301251C Compound of alpha, beta and beta, gamma unsaturation carboxylate class of possessing weeding activity
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179807 5-substituted-2-arylpyrazines
02/20/2007US7179803 Method of modulating ion channel functional activity
02/15/2007WO2007018640A1 New capped pyrazinoylguanidine sodium channel blockers
02/15/2007US20070037980 under pressure at elevated temperature, by discharging the ethylenediamine at the top and the piperazine at the bottom of a distillation column
02/15/2007US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
02/15/2007US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/15/2007CA2820233A1 Perylenequinone derivatives and uses thereof
02/15/2007CA2617269A1 New capped pyrazinoylguanidine sodium channel blockers
02/14/2007EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/14/2007EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
02/14/2007EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
02/14/2007EP0999256B1 Compounds for organic el element and organic el element
02/14/2007CN1913778A Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
02/14/2007CN1911914A Process for distillatively removing piperazine from an ethylenediamine-piperazine mixture
02/13/2007US7176312 Kinase inhibitor scaffolds and methods for their preparation
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007CA2122236C Quinolines and their analogs
02/08/2007WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors
02/08/2007WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
02/08/2007US20070032509 New capped pyrazinoylguanidine sodium channel blockers
02/08/2007US20070032499 Novel cysteine protease inhibitors and their therapeutic applications
02/08/2007CA2616682A1 Squaric acid derivatives as protein kinase inhibitors
02/07/2007EP1749823A1 Amine compound and organic electroluminescent element employing the same
02/07/2007EP1749822A1 Novel cysteine protease inhibitors and their therapeutic applications
02/07/2007EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
02/07/2007EP1749032A1 Alkoxyamines containing a radically polymerizable group
02/07/2007EP1748987A2 2-propene-1-ones as hsp 70 inducers
02/07/2007EP1651622B1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds
02/07/2007CN1910166A Heteroaryl-ureas and their use as glucokinase activators
02/07/2007CN1907985A N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof
02/07/2007CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application
02/07/2007CN1298704C Isatine derivatives with neurotrophic activity
02/06/2007US7173154 Transfection reagents
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 187